Your browser doesn't support javascript.
loading
Postnatal Expansion, Maturation, and Functionality of MR1T Cells in Humans.
Swarbrick, Gwendolyn M; Gela, Anele; Cansler, Meghan E; Null, Megan D; Duncan, Rowan B; Nemes, Elisa; Shey, Muki; Nsereko, Mary; Mayanja-Kizza, Harriet; Kiguli, Sarah; Koh, Jeffrey; Hanekom, Willem A; Hatherill, Mark; Lancioni, Christina; Lewinsohn, David M; Scriba, Thomas J; Lewinsohn, Deborah A.
Afiliação
  • Swarbrick GM; Division of Infectious Diseases, Department of Pediatrics, Oregon Health & Science University, Portland, OR, United States.
  • Gela A; Portland Veterans Administration Healthcare System, Portland, OR, United States.
  • Cansler ME; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Null MD; Division of Infectious Diseases, Department of Pediatrics, Oregon Health & Science University, Portland, OR, United States.
  • Duncan RB; Division of Infectious Diseases, Department of Pediatrics, Oregon Health & Science University, Portland, OR, United States.
  • Nemes E; Division of Infectious Diseases, Department of Pediatrics, Oregon Health & Science University, Portland, OR, United States.
  • Shey M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Nsereko M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Mayanja-Kizza H; Department of Medicine & Wellcome Centre for Infectious Disease Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Kiguli S; Uganda-CWRU Research Collaboration, Kampala, Uganda.
  • Koh J; Uganda-CWRU Research Collaboration, Kampala, Uganda.
  • Hanekom WA; Department of Medicine, Makerere University, Kampala, Uganda.
  • Hatherill M; Uganda-CWRU Research Collaboration, Kampala, Uganda.
  • Lancioni C; Department of Paediatrics, Makerere University, Kampala, Uganda.
  • Lewinsohn DM; Department of Anesthesiology and Perioperative Medicine, Oregon Health & Science University, Portland, OR, United States.
  • Scriba TJ; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Lewinsohn DA; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Front Immunol ; 11: 556695, 2020.
Article em En | MEDLINE | ID: mdl-33042140
ABSTRACT
MR1-restricted T (MR1T) cells are defined by their recognition of metabolite antigens presented by the monomorphic MHC class 1-related molecule, MR1, the most highly conserved MHC class I related molecule in mammalian species. Mucosal-associated invariant T (MAIT) cells are the predominant subset of MR1T cells expressing an invariant TCR α-chain, TRAV1-2. These cells comprise a T cell subset that recognizes and mediates host immune responses to a broad array of microbial pathogens, including Mycobacterium tuberculosis. Here, we sought to characterize development of circulating human MR1T cells as defined by MR1-5-OP-RU tetramer labeling and of the TRAV1-2+ MAIT cells defined by expression of TRAV1-2 and high expression of CD26 and CD161 (TRAV1-2+CD161++CD26++ cells). We analyzed postnatal expansion, maturation, and functionality of peripheral blood MR1-5-OP-RU tetramer+ MR1T cells in cohorts from three different geographic settings with different tuberculosis (TB) vaccination practices, levels of exposure to and infection with M. tuberculosis. Early after birth, frequencies of MR1-5-OP-RU tetramer+ MR1T cells increased rapidly by several fold. This coincided with the transition from a predominantly CD4+ and TRAV1-2- population in neonates, to a predominantly TRAV1-2+CD161++CD26++ CD8+ population. We also observed that tetramer+ MR1T cells that expressed TNF upon mycobacterial stimulation were very low in neonates, but increased ~10-fold in the first year of life. These functional MR1T cells in all age groups were MR1-5-OP-RU tetramer+TRAV1-2+ and highly expressed CD161 and CD26, markers that appeared to signal phenotypic and functional maturation of this cell subset. This age-associated maturation was also marked by the loss of naïve T cell markers on tetramer+ TRAV1-2+ MR1T cells more rapidly than tetramer+TRAV1-2- MR1T cells and non-MR1T cells. These data suggest that neonates have infrequent populations of MR1T cells with diverse phenotypic attributes; and that exposure to the environment rapidly and preferentially expands the MR1-5-OP-RU tetramer+TRAV1-2+ population of MR1T cells, which becomes the predominant population of functional MR1T cells early during childhood.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND / 4_TD Base de dados: MEDLINE Assunto principal: Células T Invariantes Associadas à Mucosa Limite: Adolescent / Child / Child, preschool / Humans / Infant / Newborn Idioma: En Revista: Front Immunol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND / 4_TD Base de dados: MEDLINE Assunto principal: Células T Invariantes Associadas à Mucosa Limite: Adolescent / Child / Child, preschool / Humans / Infant / Newborn Idioma: En Revista: Front Immunol Ano de publicação: 2020 Tipo de documento: Article